Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Description complète

Détails bibliographiques

Auteurs principaux:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2023-02-01
Collection:	Frontiers in Surgery
Sujets:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!